
    
      To improve the management of PAH patients through an evidence-based approach aimed at
      achieving optimal WHO functional class (defined as: 1) improvement of FC III or IV to FC II;
      2) improvement of FC II to FC I; or 3) maintaining FC II or I)
    
  